Netherlands
# |
Name |
Operating Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD -4.88 M
|
Dec. 31, 2023 | USD 8.76 | -0.46% |
|
Netherlands |
|
2 |
USD -19.09 M
|
Dec. 31, 2023 | USD 127.21 | -1.46% |
|
Netherlands |
|
3 |
USD -35.16 M
|
Dec. 31, 2023 | USD 2.12 | -1.40% |
|
Netherlands |
|
4 |
USD -43.25 M
|
Dec. 31, 2023 | USD 0.98 | -1.01% |
|
Netherlands |
|
5 |
USD -106.97 M
|
Dec. 31, 2023 | USD 17.60 | -0.73% |
|
Netherlands |
|
6 |
USD -156.55 M
|
Dec. 31, 2023 | USD 40.94 | -1.52% |
|
Netherlands |
|
7 |
USD -165.73 M
|
Dec. 31, 2023 | USD 22.29 | 2.39% |
|
Netherlands |
|
8 |
USD -282.87 M
|
Dec. 31, 2023 | USD 15.74 | -0.32% |
|
Netherlands |
|
9 |
USD -425.05 M
|
Dec. 31, 2023 | USD 662.53 | -0.67% |
|
Netherlands |
The Pharmaceuticals company in Netherlands with the highest Operating Income is Pharming Group N.V. (NasdaqGM: PHAR) at USD -4.88 M.
The Pharmaceuticals company in Netherlands with the lowest Operating Income is argenx SE (Brussels Stock Exchange: ARGX.BR) at USD -425.05 M.
The top 10 Pharmaceuticals companies in Netherlands by Operating Income are Pharming Group N.V., Redcare Pharmacy NV, ProQR Therapeutics N.V., LAVA Therapeutics N.V., Pharvaris N.V., Merus N.V., NewAmsterdam Pharma Company N.V., uniQure N.V. and argenx SE.
The bottom 10 Pharmaceuticals companies in Netherlands by Operating Income are argenx SE, uniQure N.V., NewAmsterdam Pharma Company N.V., Merus N.V., Pharvaris N.V., LAVA Therapeutics N.V., ProQR Therapeutics N.V., Redcare Pharmacy NV and Pharming Group N.V..